Mavelertinib
Mavelertinib Uses, Dosage, Side Effects, Food Interaction and all others data.
Mavelertinib is under investigation in clinical trial NCT02349633 (Study for Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M)).
| Trade Name | Mavelertinib |
| Generic | Mavelertinib |
| Mavelertinib Other Names | Egfr t790m inhibitor pf-06747775, Mavelertinib |
| Type | |
| Formula | C18H22FN9O2 |
| Weight | Average: 415.433 Monoisotopic: 415.188049147 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Mavelertinib
